🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. Lecanemab 10 mg/kg

    The First People's Hospital of Lianyungang

    Alzheimer s Disease

    approved small molecule active

    1 trial

  2. Levobupivacaine

    United Therapeutics Europe Ltd

    Arthroplasty, Replacement, Knee

    approved small molecule active

    1 trial

  3. Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho

    The George Institute

    Hip fracture

    approved small molecule active

    1 trial

  4. Levocarnitine Injection

    The First People's Hospital of Lianyungang

    Renal Dialysis

    approved small molecule completed

    1 trial

  5. Levothyroxine

    The First People's Hospital of Lianyungang

    Heart Failure

    approved small molecule active

    1 trial

  6. Levothyroxine

    United Therapeutics Europe Ltd

    Hypothyroidism

    approved small molecule completed

    1 trial

  7. Live Combined Bifidobacterium and Lactobacillus

    The First People's Hospital of Lianyungang

    Functional Constipation

    approved small molecule active

    1 trial

  8. Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets

    The George Institute

    High risk atrial fibrillation patients with previous intracranial hemorrhage

    approved small molecule active

    1 trial

  9. Longidaza

    The First People's Hospital of Lianyungang

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  10. Low dose Oliceridine

    The First People's Hospital of Lianyungang

    Oliceridine

    approved small molecule active

    1 trial

  11. Maggot debridement therapy

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcers

    approved other active

    1 trial

  12. Mailed nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  13. Managed Ventricular Pacing programmed ON/OFF

    Rhythm Pharmaceuticals Netherlands B.V.

    Cardiovascular Diseases

    approved other completed

    1 trial

  14. Medtronic AT500

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  15. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial

  16. Menjugate

    United Therapeutics Europe Ltd

    Meningococcal Disease

    approved mab completed

    1 trial

  17. Mesalazine

    The First People's Hospital of Lianyungang

    Ulcerative Colitis, Unspecified

    approved small molecule active

    1 trial

  18. Mesalazine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome With Diarrhoea

    approved small molecule completed

    1 trial

  19. Metformin Actavis 500 mg filmdragerad tablett

    The George Institute

    Polycystic ovary syndrome

    approved small molecule active

    1 trial

  20. Methimazole

    The First People's Hospital of Lianyungang

    Graves Disease

    approved small molecule active

    1 trial

  21. Methotrexate

    United Therapeutics Europe Ltd

    Psoriatic Arthritis

    approved small molecule completed

    1 trial

  22. Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule

    The George Institute

    lumbosacral radiculalgia

    approved small molecule active

    1 trial

  23. Mifepristone

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy Related

    approved small molecule completed

    1 trial

  24. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources